Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
01/2011
01/13/2011US20110009638 Method for preparing 3-trifluoromethyl chalcones
01/13/2011US20110009448 Compound
01/13/2011US20110009371 Synthesis of tetracyclines and analogues thereof
01/13/2011US20110009261 Chemical compounds
01/13/2011US20110008255 Beta-amyloid pet imaging agents
01/12/2011EP2272973A1 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
01/12/2011EP2272972A1 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
01/12/2011EP2272835A1 Novel five-membered ring compound
01/12/2011EP1896435B1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
01/12/2011EP1517907B1 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
01/12/2011EP1274695B1 New thiazol compounds and their preparations
01/12/2011CN101945859A Bis-(sulfonylamino) derivatives in therapy
01/12/2011CN101941917A Amide compounds and use thereof
01/11/2011US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011US7868179 such as N-acetyl-N-(4'-bromo-1,1'-biphenyl-2-yl)-4-(difluoromethyl)-2-methyl-1,3-thiazole-5-carboxamide, used for controlling unwanted phytopathogenic fungi; microbiocides
01/11/2011US7868030 Fructose-1,6-bisphosphatase (FBPase) inhibitors, such as N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]3(difluoromethoxy)benzenesulfonamide, used as antidiabetic agents
01/11/2011US7868029 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates
01/11/2011US7868004 when applied to the skin or mouth in the form of orally ingestible foods or beverages, tobacco products, creams, ointments, sprays, mouthwashes, dentifrice or toiletries; N-4-(pyrazol-1-yl)-phenyl-3-p-menthanecarboxamide
01/11/2011CA2469876C Benzothiazoles
01/11/2011CA2461439C Novel .alpha.-oxygenated or .alpha.-thiolated carboxylic acid phenethylamide derivatives
01/11/2011CA2385592C Benzamides and related inhibitors of factor xa
01/11/2011CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors
01/06/2011WO2011002067A1 Heterocyclic compound and use thereof
01/06/2011WO2010111303A3 Imaging agents for detecting neurological disorders
01/06/2011WO2010098600A3 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
01/06/2011US20110003992 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
01/06/2011US20110003826 Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
01/05/2011EP2270107A1 Compounds for Dual Photodiagnosis and Therapy
01/05/2011EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands
01/05/2011EP2269997A2 Method for producing aminothiazole derivative and production intermediate
01/05/2011EP2269992A1 Bicyclic pyrimidinones for the treatment of viral infections
01/05/2011EP2269975A2 Method for producing aminothiazole derivative and production intermediate
01/05/2011EP2269064A1 Protein labeling with cyanobenzothiazole conjugates
01/05/2011EP2268625A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
01/05/2011EP2268616A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
01/05/2011EP2268606A1 4-dimethylaminobutyric acid derivatives
01/05/2011EP2146974B1 N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
01/05/2011EP1661890B1 Ppar-activating compound and pharmaceutical composition containing same
01/05/2011EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain
01/05/2011CN101935310A Refining process of famotidine raw material
01/05/2011CN101362735B Preparation method of ethyl 2-[[(bezyloxy)carbonyl]amido]-4-thiazolyl acetate
01/04/2011US7863313 Methods for the treatment of inflammatory diseases
01/04/2011US7863305 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors
01/04/2011US7863304 Which protect neural cells from degeneration and/or death in response to injury or disease; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease
01/04/2011US7863303 Insecticidal N-substituted (2-substituted-1,3-thiazol)alkyl sulfoximines
01/04/2011US7863302 Compounds and methods for modulating FX-receptors
01/04/2011US7863263 prostaglandin receptor agonists such as 2-[(2-{(1R,2R)-2-[(1E,4S)-4-hydroxy-7-methyl-1,7-octadien-1-yl]-5-oxocyclopentyl}ethyl)thio]-1,3-thiazole-4-carboxylic acid, salt or cyclodextrin clathrate thereof, used as neuroprotectants or for the therapy of nervous system disorders
01/04/2011CA2595782C Process for producing thiazolidinedione compound and production intermediate thereof
01/04/2011CA2488363C O-substituted hydroxyaryl derivatives
01/04/2011CA2451238C Cyclic diamine compound with 5 membered ring groups
01/04/2011CA2365085C Therapeutic agents for diabetes
12/2010
12/30/2010US20100331551 Alpha-haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom
12/30/2010US20100331540 Method for producing compound having deuterated aromatic ring or heterocyclic ring
12/30/2010US20100331379 Benzamide glucokinase activators
12/30/2010US20100331378 Aminotriazole derivatives as alx agonists
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331304 Compounds Which Modulate The CB2 Receptor
12/30/2010US20100330021 Substituted (thiazol-2-yl)-amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
12/30/2010US20100326526 Emissive aryl-heteroaryl compounds
12/30/2010US20100325915 Orthopedic insoles for protecting skin from stretching and cracking in the area of the five metatarsal heads of the forefoot
12/29/2010WO2010150557A1 Rubber crawler
12/29/2010WO2010150206A1 N-substituted-n-phenylethylsulfonamides for the identification of biological and pharmacological activity
12/29/2010WO2010149310A1 Di-substituted phenyloxy(thio)phenylamide benzoxa(thia)zoles
12/29/2010WO2010149283A2 Phenyloxy(thio)phenylamidobenzoxa(thia)zoles
12/29/2010WO2010148963A1 Compounds having activity against hepatitis virus and use thereof
12/29/2010WO2010148650A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148649A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148488A1 Cathepsin cysteine protease inhibitors for the treatment of various diseases
12/29/2010WO2010122578A3 Process for preparation of sitagliptin and its intermediates
12/29/2010EP2266966A1 A process for the preparation of febuxostat
12/29/2010EP2266960A2 Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants
12/29/2010EP2266665A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/29/2010EP2265579A2 2-cyanobenzensulfonamide derivatives having pesticidal properties
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010EP1292573B1 Substituted thioacetamides
12/29/2010CN101932568A Thiazole derivative and use thereof as vap-1 inhibitor
12/29/2010CN101929988A Method for detecting febuxostat-associated matters by using high performance liquid chromatography
12/29/2010CN101928261A Method for producing 2,2'-dibenzothiazolyl disulfide by nitric acid one-step method
12/29/2010CN101928260A Febuxostat new crystal form and preparation method thereof
12/29/2010CN101928259A 2-arylthiazole derivative and medicament composition thereof
12/29/2010CN101928258A 1-(2-substituted phenylamino-4-methyl-thiazole-5)-3-substituted phenyl-acrylketone derivative, preparation method and pharmaceutical application thereof
12/29/2010CN101928193A Method for preparing symmetrical disulfide compound
12/29/2010CN101081839B Refining technique of famotidine raw material
12/29/2010CA2764956A1 Novel biphenyl and phenyl-pyridine amides
12/28/2010US7858650 Medicinal composition for inhalation
12/28/2010US7858600 Non-antibiotic resistant; Gram-positive and Gram-negative bacteria; Salmonella, Streptococcus, Escherichia
12/23/2010WO2010147830A2 Aminothiazole modulators of beta-3-adrenoreceptor
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2010094666A3 Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
12/23/2010WO2010010435A3 Fused oxazole and thiazole derivatives as trpms modulators
12/23/2010US20100324301 Sulfenamide, vulcanization accelerator containing the sulfenamide for rubber, and process for producing the vulcanization accelerator
12/23/2010US20100324096 Whitening Agent And Skin External Preparation
12/23/2010US20100324086 Compounds and methods
12/23/2010US20100324071 Novel glucokinase activators and methods of using same
12/23/2010US20100324058 thrombin function compounds and pharmaceutical compositions based on them
12/23/2010US20100324046 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/23/2010US20100324032 Compounds and uses thereof in modulating amyloid beta
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 337